{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T08:59:06Z","timestamp":1776070746763,"version":"3.50.1"},"reference-count":32,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine"],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1016\/j.cyto.2012.02.013","type":"journal-article","created":{"date-parts":[[2012,3,17]],"date-time":"2012-03-17T07:30:37Z","timestamp":1331969437000},"page":"351-354","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Monocyte chemoattractant protein-1 in schizophrenia: \u22122518A\/G genetic variant and protein levels in Armenian population"],"prefix":"10.1016","volume":"58","author":[{"given":"Roksana","family":"Zakharyan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Boyajyan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arsen","family":"Arakelyan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maya","family":"Melkumova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frantisek","family":"Mrazek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Petrek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cyto.2012.02.013_b0005","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.neulet.2004.10.024","article-title":"Classical pathway complement activity in schizophrenia","volume":"374","author":"Hakobyan","year":"2005","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.cyto.2012.02.013_b0010","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/BF03033242","article-title":"Schizophrenia as an inflammation-mediated dysbalance of glutamatergic neurotransmission","volume":"10","author":"Muller","year":"2006","journal-title":"Neurotox Res"},{"key":"10.1016\/j.cyto.2012.02.013_b0015","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/1471-244X-7-46","article-title":"Inflammation-related genes up-regulated in schizophrenia brains","volume":"7","author":"Saetre","year":"2007","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.cyto.2012.02.013_b0020","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.clinbiochem.2007.11.014","article-title":"Cryoglobulins as indicators of upregulated immune response in schizophrenia","volume":"41","author":"Boyajyan","year":"2008","journal-title":"Clin Biochem"},{"key":"10.1016\/j.cyto.2012.02.013_b0025","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/j.1440-1819.2009.01945.x","article-title":"Cytokines and schizophrenia: microglia hypothesis of schizophrenia","volume":"63","author":"Monji","year":"2009","journal-title":"Psychiatry Clin Neurosci"},{"key":"10.1016\/j.cyto.2012.02.013_b0030","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1007\/s11064-010-0126-2","article-title":"Alternative complement pathway in schizophrenia","volume":"35","author":"Boyajyan","year":"2010","journal-title":"Neurochem Res"},{"key":"10.1016\/j.cyto.2012.02.013_b0035","first-page":"97","article-title":"The role of brain developmental abnormalities in the pathogenesis of schizophrenia","volume":"110","author":"Khoyetsyan","year":"2010","journal-title":"Zh Nevrol Psikhiatr Im SS Korsakova"},{"key":"10.1016\/j.cyto.2012.02.013_b0040","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.bbi.2006.11.009","article-title":"-G308A tumor necrosis factor alpha functional polymorphism and schizophrenia risk: meta-analysis plus association study","volume":"21","author":"Sacchetti","year":"2007","journal-title":"Brain Behav Immun"},{"key":"10.1016\/j.cyto.2012.02.013_b0045","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.biopsych.2007.09.024","article-title":"Inflammatory cytokine alterations in schizophrenia: a systematic quantitative review","volume":"63","author":"Potvin","year":"2008","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.cyto.2012.02.013_b0050","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1111\/j.1399-5618.2009.00757.x","article-title":"Similar immune profile in bipolar disorder and schizophrenia: selective increase in soluble tumor necrosis factor receptor I and von Willebrand factor","volume":"11","author":"Hope","year":"2009","journal-title":"Bipolar Disord"},{"key":"10.1016\/j.cyto.2012.02.013_b0055","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1007\/s12031-010-9365-6","article-title":"Functional polymorphism in the interleukin-6 and interleukin-10 genes in patients with paranoid schizophrenia: a case-control study","volume":"42","author":"Paul-Samojedny","year":"2010","journal-title":"J Mol Neurosci"},{"key":"10.1016\/j.cyto.2012.02.013_b0060","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.schres.2006.06.037","article-title":"Association study of IL10, IL1beta, and IL1RN and schizophrenia using tag SNPs from a comprehensive database: suggestive association with rs16944 at IL1beta","volume":"88","author":"Shirts","year":"2006","journal-title":"Schizophr Res"},{"key":"10.1016\/j.cyto.2012.02.013_b0065","first-page":"7","article-title":"Monocyte chemoattractant protein-1","volume":"72","author":"Gu","year":"1999","journal-title":"Chem Immunol"},{"key":"10.1016\/j.cyto.2012.02.013_b0070","first-page":"153","article-title":"CCL2 (MCP-1) and CCL5 (RANTES) levels in the peripheral blood of multiple sclerosis patients treated with Glatiramer Acetate (Copaxone)","volume":"43","author":"Losy","year":"2005","journal-title":"Folia Neuropathol"},{"key":"10.1016\/j.cyto.2012.02.013_b0075","doi-asserted-by":"crossref","first-page":"2695","DOI":"10.1161\/hs1101.097380","article-title":"Monocyte chemoattractant protein-1 is increased in the cerebrospinal fluid of patients with ischemic stroke","volume":"32","author":"Losy","year":"2001","journal-title":"Stroke"},{"key":"10.1016\/j.cyto.2012.02.013_b0080","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1097\/00002030-199811000-00014","article-title":"Elevated cerebrospinal fluid levels of monocyte chemotactic protein-1 correlate with HIV-1 encephalitis and local viral replication","volume":"12","author":"Cinque","year":"1998","journal-title":"AIDS"},{"key":"10.1016\/j.cyto.2012.02.013_b0085","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1097\/01.ypg.0000128764.07344.06","article-title":"Monocyte chemoattractant protein-1 promoter \u22122518 polymorphism and schizophrenia in the Korean population","volume":"14","author":"Pae","year":"2004","journal-title":"Psychiatr Genet"},{"key":"10.1016\/j.cyto.2012.02.013_b0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/ajmg.b.30100","article-title":"MCP-1 gene (SCYA2) and schizophrenia: a case-control association study","volume":"132B","author":"Mundo","year":"2005","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"10.1016\/j.cyto.2012.02.013_b0095","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1471-2202-12-13","article-title":"Dysregulation of chemo-cytokine production in schizophrenic patients vs healthy controls","volume":"12","author":"Reale","year":"2011","journal-title":"BMC Neurosci"},{"key":"10.1016\/j.cyto.2012.02.013_b0100","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/j.1365-2362.2009.02125.x","article-title":"STrengthening the REporting of Genetic Association studies (STREGA) \u2013 an extension of the STROBE statement","volume":"39","author":"Little","year":"2009","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.cyto.2012.02.013_b0105","series-title":"Structured clinical interview for DSM-IV-TR axis I disorders, non-patient edition (SCID-I\/NP)","author":"First","year":"2001"},{"key":"10.1016\/j.cyto.2012.02.013_b0110","series-title":"Molecular cloning: a laboratory manual","author":"Sambrook","year":"2001"},{"key":"10.1016\/j.cyto.2012.02.013_b0115","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/j.1399-0039.1995.tb03127.x","article-title":"Phototyping: comprehensive DNA typing for HLA-A, B, C, DRB3, DRB4, DRB5&DQB1 by PCR with 144 primer mixes utilizing sequence-specific primers (PCR-SSP)","volume":"6","author":"Bunce","year":"1995","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.cyto.2012.02.013_b0120","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0895-7061(01)02285-3","article-title":"Power and replication in case-control studies","volume":"15","author":"Lalouel","year":"2002","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.cyto.2012.02.013_b0125","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/j.exger.2004.05.001","article-title":"Monocyte chemoattractant protein-1 (MCP-1) gene polymorphism and risk of Alzheimer\u2019s disease in Italians","volume":"39","author":"Pola","year":"2004","journal-title":"Exp Gerontol"},{"key":"10.1016\/j.cyto.2012.02.013_b0130","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.neulet.2004.01.035","article-title":"No evidence for association of the monocyte chemoattractant protein-1 (-2518) gene polymorphism and Alzheimer\u2019s disease","volume":"360","author":"Combarros","year":"2004","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.cyto.2012.02.013_b0135","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/j.neurobiolaging.2003.11.008","article-title":"MCP-1 in Alzheimer\u2019s disease patients: A-2518G polymorphism and serum levels","volume":"25","author":"Fenoglio","year":"2004","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.cyto.2012.02.013_b0140","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.neulet.2004.08.016","article-title":"Chemokines (RANTES and MCP-1) and chemokine-receptors (CCR2 and CCR5) gene polymorphisms in Alzheimer\u2019s and Parkinson\u2019s disease","volume":"370","author":"Huerta","year":"2004","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.cyto.2012.02.013_b0145","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.jad.2010.04.007","article-title":"A genome-wide association study of bipolar disorder in Norwegian individuals, followed by replication in Icelandic sample","volume":"126","author":"Djurovic","year":"2010","journal-title":"J Affect Disord"},{"key":"10.1016\/j.cyto.2012.02.013_b0150","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.schres.2008.03.018","article-title":"Patients with schizophrenia show raised serum levels of the pro-inflammatory chemokine CCL2: association with the metabolic syndrome in patients","volume":"102","author":"Drexhage","year":"2008","journal-title":"Schizophr Res"},{"key":"10.1016\/j.cyto.2012.02.013_b0155","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.pnpbp.2007.11.019","article-title":"Increased serum levels of CCL11\/eotaxin in schizophrenia","volume":"32","author":"Teixeira","year":"2008","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.cyto.2012.02.013_b0160","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1161\/CIRCULATIONAHA.105.543579","article-title":"CCL2 polymorphisms are associated with serum monocyte chemoattractant protein-1 levels and myocardial infarction in the Framingham Heart Study","volume":"112","author":"McDermott","year":"2005","journal-title":"Circulation"}],"container-title":["Cytokine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466612000658?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466612000658?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T20:49:08Z","timestamp":1760906948000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043466612000658"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6]]},"references-count":32,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["S1043466612000658"],"URL":"https:\/\/doi.org\/10.1016\/j.cyto.2012.02.013","relation":{},"ISSN":["1043-4666"],"issn-type":[{"value":"1043-4666","type":"print"}],"subject":[],"published":{"date-parts":[[2012,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Monocyte chemoattractant protein-1 in schizophrenia: \u22122518A\/G genetic variant and protein levels in Armenian population","name":"articletitle","label":"Article Title"},{"value":"Cytokine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cyto.2012.02.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}